Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Novartis Tetravalent Influenza Vaccine Containing H5N1 in Adults
2007-002712-25Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2007
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Tetravalent Influenza Vaccine-University of Cape Town in Avian Influenza (AI) (3 arms), sponsored by Novartis. Primary endpoints: Primary immunogenicity endpoints and Safety endpoints. Started Aug 2007; status: completed.
02
Drugs
Tetravalent Influenza Vaccine-University of Cape Town
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on 2007-002712-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002712-25.